Search Results - "Salzman, Donna"

Refine Results
  1. 1

    In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia by Minagawa, Kentaro, Jamil, Muhammad O, Al-Obaidi, Mustafa, Pereboeva, Larisa, Salzman, Donna, Erba, Harry P, Lamb, Lawrence S, Bhatia, Ravi, Mineishi, Shin, Di Stasi, Antonio

    Published in PloS one (01-12-2016)
    “…Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy…”
    Get full text
    Journal Article
  2. 2

    Combinatorial suicide gene strategies for the safety of cell therapies by Falcon, Corey, Smith, Lauren, Al-Obaidi, Mustafa, Abu Zaanona, Mohammed, Purvis, Katelyn, Minagawa, Kentaro, Athar, Mohammad, Salzman, Donna, Bhatia, Ravi, Goldman, Frederick, Di Stasi, Antonio

    Published in Frontiers in immunology (14-09-2022)
    “…Gene-modified cellular therapies carry inherent risks of severe and potentially fatal adverse events, including the expansion of alloreactive cells or…”
    Get full text
    Journal Article
  3. 3

    Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients by Hodgson, Brian D., Margolis, David M., Salzman, Donna E., Eastwood, Dan, Tarima, Sergey, Williams, Lisa D., Sande, Jane E., Vaughan, William P., Whelan, Harry T.

    Published in Supportive care in cancer (01-07-2012)
    “…Purpose This study seeks to investigate the use of extra-orally applied near-infrared phototherapy for the reduction of oral pain secondary to chemotherapy-…”
    Get full text
    Journal Article
  4. 4

    Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies by Parks, Katherine, Diebold, Kendall, Salzman, Donna, Di Stasi, Antonio, Al‐Kadhimi, Zaid, Espinoza‐Gutarra, Manuel, Bhatia, Ravi, Jamy, Omer

    Published in EJHaem (01-06-2024)
    “…Relapse remains a major cause of treatment failure following allogeneic stem cell transplantation (allo‐SCT) for patients with acute myeloid leukemia (AML) and…”
    Get full text
    Journal Article
  5. 5

    Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients by Baddley, John W., Stroud, Thomas P., Salzman, Donna, Pappas, Peter G.

    Published in Clinical infectious diseases (01-05-2001)
    “…Invasive mold infections (IMIs) are an important cause of morbidity and mortality in patients who are undergoing bone marrow transplantation (BMT). To examine…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies by Parks, Katherine, Diebold, Kendall, Salzman, Donna, Di Stasi, Antonio, Espinoza-Gutarra, Manuel, Bhatia, Ravi, Al-Kadhimi, Zaid, Jamy, Omer

    Published in Blood (02-11-2023)
    “…Background: Allogeneic stem cell transplantation (allo-SCT) is potentially curative for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome…”
    Get full text
    Journal Article
  9. 9

    Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation by Jamy, Omer, Dasher, John, Chen, Alice, Salzman, Donna, Bhatia, Ravi, Bhatia, Smita

    Published in Bone marrow transplantation (Basingstoke) (01-03-2023)
    “…Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-hsct) can require intensive care unit (ICU) admission in the post-transplant…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Older Patients Using Fludarabine and Total Body Irradiation by Jamy, Omer Hassan, Arora, Sankalp, Salzman, Donna, Di Stasi, Antonio, Minagawa, Kentaro, Mineishi, Shin, Saad, Ayman

    Published in Blood (23-11-2021)
    “…Background: Older adults with acute lymphoblastic leukemia (ALL) have poor survival outcomes. Although allogeneic hemaptopoietic stem cell transplantation…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Risk Factors and Outcomes of ICU Admission Following Allogeneic Hematopoietic Stem Cell Transplantation by Jamy, Omer Hassan, Dasher, John, Chen, Yanjun, Battles, Kevin D., Salzman, Donna, Di Stasi, Antonio, Bhatia, Ravi, Bhatia, Smita

    Published in Blood (23-11-2021)
    “…Background: Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-hsct) can develop complications such as life-threatening infections,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20